LACTAID Extra Strength
Natural health product licensed in Canada
- Licence holder
- Kenvue Canada Inc.
- NPN or DIN-HM
- 02230654
- Status
- Active licence
- Licence date
- 7 January 2008
- Revision date
- 26 July 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 4,500 FCC LU | Not calculated |
Non-medicinal ingredients
Cellulose - microcrystalline, Stéarate de magnésium, Stéarate de magnésium d'origine végétale, mannitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | Not specified | 2 Comprimé | 3 Tous les jours |
Uses authorised in Canada
For lactose intolerance. LACTAID lactase enzyme makes milk and other dairy products more digestible for those who have difficulty digesting lactose. Extra Strength LACTAID tablets convert the lactose into a digestible form. Extra Strength LACTAID tablets can help prevent the gas, bloating and diarrhea that result from this condition.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, bloating or hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 02230654
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging